Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-22,044
Closed -$48K 1408
2022
Q3
$48K Sell
22,044
-2,906
-12% -$10K ﹤0.01% 1330
2022
Q2
$87K Buy
24,950
+44
+0.2% +$164 ﹤0.01% 1309
2022
Q1
$126K Sell
24,906
-3,686
-13% -$18.7K ﹤0.01% 1259
2021
Q4
$179K Buy
28,592
+130
+0.5% +$888 ﹤0.01% 1234
2021
Q3
$226K Sell
28,462
-1,230
-4% -$10.1K 0.01% 1170
2021
Q2
$222K Buy
29,692
+1,610
+6% +$11.2K ﹤0.01% 1207
2021
Q1
$170K Buy
+28,082
New +$216K ﹤0.01% 1186

Other funds holding VXRT

Shell Asset Management's VXRT Position: Q4 2022 in Review

Shell Asset Management sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 22,044 shares — an estimated $48K sold.

Shell Asset Management first reported a position in VXRT in Q1 2021 and held it in 7 quarters. The position peaked at $226K in Q3 2021. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

  • Shell Asset Management reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
  • Shell Asset Management sold 22,044 Vaxart shares in Q4 2022, an estimated $48K.
  • Shell Asset Management first reported a position in Vaxart in Q1 2021 and held it in 7 quarters.
  • Shell Asset Management's Vaxart position peaked at $226K in Q3 2021.
  • 132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Shell Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.